What goes into the coverage, or formulary, decisions that health insurers make? A lack of transparency in the process can make it hard to tell. As a result, coverage decisions (and, ultimately, access to treatments) are often unpredictable to patients, providers and biopharmaceutical manufacturers.
On September 10 at 1 p.m. ET, the National Pharmaceutical Council (NPC) is hosting a webinar to discuss this issue and approaches to increasing the clarity, consistency and transparency of formulary decision-making. Speakers will include:
- Dr. Jennifer Graff, Director, Comparative Effectiveness Research, National Pharmaceutical Council
- Dr. Saira Jan, Director of Clinical Pharmacy Management, Horizon Blue Cross Blue Shield of New Jersey; Clinical Professor, Rutgers State University of New Jersey
- Dr. Bonnie Dean, Principal Investigator, Research Services, Cerner Research
- Dr. Kelly Ko, Research Scientist, Cerner Research
- Dr. Robert W. Dubois, Chief Science Officer, National Pharmaceutical Council (moderator)
The panel will discuss a research effort by NPC, Cerner Research and the University of Pennsylvania to develop and test a more structured approach to formulary decision-making. They will share what was learned, as well as future directions for improving the transparency of the process. Their findings are detailed in the August edition of the peer-reviewed journal Pharmacy and Therapeutics (P&T).
There is no cost to attend this webinar. Please click here to register, and join the conversation on Twitter using the hashtag #npcwebinar.